Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

4.57
Delayed Data
As of 3:59pm ET
 -0.11 / -2.35%
Today’s Change
2.94
Today|||52-Week Range
20.48
-6.35%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Y-mAbs Therapeutics Inc have a median target of 9.00, with a high estimate of 20.00 and a low estimate of 4.00. The median estimate represents a +96.94% increase from the last price of 4.57.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Y-mAbs Therapeutics Inc. This rating has held steady since January, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.46
Sales
$19.7M
Reporting Date
Feb 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 27.16%
 
 
 
 
 
 
Growthannually -106.16%
 
 
 
 
 
 

Sales

Growthquarterly 57.24%
 
 
 
 
 
 
Growthannually 55.58%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.